These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30636813)

  • 1. Mineral Trioxide Aggregate and Diluted Formocresol Pulpotomy: Prospective and Retrospective Study Outcomes.
    Ghoniem N; Vaidyanathan V; Zealand CM; Sushynski JM; Mettlach SM; Botero TM; Majewski RF; Boynton JR; Hu JC
    J Mich Dent Assoc; 2018 Apr; 100(4):40-65. PubMed ID: 30636813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of mineral trioxide aggregate and diluted formocresol in pulpotomized human primary molars: 42-month follow-up and survival analysis.
    Mettlach SE; Zealand CM; Botero TM; Boynton JR; Majewski RF; Hu JC
    Pediatr Dent; 2013; 35(3):E87-94. PubMed ID: 23756301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of mineral trioxide aggregate and formocresol as pulp-capping agents in pulpotomized primary teeth.
    Agamy HA; Bakry NS; Mounir MM; Avery DR
    Pediatr Dent; 2004; 26(4):302-9. PubMed ID: 15344622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulp treatment for extensive decay in primary teeth.
    Smaïl-Faugeron V; Glenny AM; Courson F; Durieux P; Muller-Bolla M; Fron Chabouis H
    Cochrane Database Syst Rev; 2018 May; 5(5):CD003220. PubMed ID: 29852056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of a novel alternative to conventional formocresol-zinc oxide eugenol pulpotomy for the treatment of pulpally involved human primary teeth: diode laser-mineral trioxide aggregate pulpotomy.
    Saltzman B; Sigal M; Clokie C; Rukavina J; Titley K; Kulkarni GV
    Int J Paediatr Dent; 2005 Nov; 15(6):437-47. PubMed ID: 16238654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of gray mineral trioxide aggregate and diluted formocresol in pulpotomized primary molars: a 6- to 24-month observation.
    Sushynski JM; Zealand CM; Botero TM; Boynton JR; Majewski RF; Shelburne CE; Hu JC
    Pediatr Dent; 2012; 34(5):120-8. PubMed ID: 23211896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of formocresol and mineral trioxide aggregate as pulpotomy agents in deciduous teeth.
    Srinivasan D; Jayanthi M
    Indian J Dent Res; 2011; 22(3):385-90. PubMed ID: 22048576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mineral trioxide aggregate vs. formocresol in pulpotomized primary molars: a preliminary report.
    Eidelman E; Holan G; Fuks AB
    Pediatr Dent; 2001; 23(1):15-8. PubMed ID: 11242724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term treatment outcome of pulpotomies in primary molars using mineral trioxide aggregate and Biodentine: a randomized clinical trial.
    Cuadros-Fernández C; Lorente Rodríguez AI; Sáez-Martínez S; García-Binimelis J; About I; Mercadé M
    Clin Oral Investig; 2016 Sep; 20(7):1639-45. PubMed ID: 26578117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of mineral trioxide aggregate and formocresol as pulp medicaments for pulpotomies in primary molars.
    Noorollahian H
    Br Dent J; 2008 Jun; 204(11):E20. PubMed ID: 18425074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and radiographic outcomes of pulpotomized primary molars treated with white or gray mineral trioxide aggregate and ferric sulfate--long-term follow-up.
    Frenkel G; Kaufman A; Ashkenazi M
    J Clin Pediatr Dent; 2012; 37(2):137-41. PubMed ID: 23534318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of formocresol and mineral trioxide aggregate in pulpotomized primary molars--2 year follow up.
    Airen P; Shigli A; Airen B
    J Clin Pediatr Dent; 2012; 37(2):143-7. PubMed ID: 23534319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of mineral trioxide aggregate and formocresol pulpotomy on vital primary teeth: a clinical and radiographic study.
    Olatosi OO; Sote EO; Orenuga OO
    Niger J Clin Pract; 2015; 18(2):292-6. PubMed ID: 25666010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical study of Mineral Trioxide Aggregate in primary molars. Comparison between Grey and White MTA--a long term follow-up (84 months).
    Cardoso-Silva C; Barbería E; Maroto M; García-Godoy F
    J Dent; 2011 Feb; 39(2):187-93. PubMed ID: 21144878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation and comparison of white mineral trioxide aggregate and formocresol medicaments in primary tooth pulpotomy: clinical and radiographic study.
    Jayam C; Mitra M; Mishra J; Bhattacharya B; Jana B
    J Indian Soc Pedod Prev Dent; 2014; 32(1):13-8. PubMed ID: 24531596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Radiographic Evaluation of the Effectiveness of Formocresol, Mineral Trioxide Aggregate, Portland Cement, and Enamel Matrix Derivative in Primary Teeth Pulpotomies: A Two Year Follow-Up.
    Yildirim C; Basak F; Akgun OM; Polat GG; Altun C
    J Clin Pediatr Dent; 2016; 40(1):14-20. PubMed ID: 26696101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing gray mineral trioxide aggregate and diluted formocresol in pulpotomized human primary molars.
    Zealand CM; Briskie DM; Botero TM; Boynton JR; Hu JC
    Pediatr Dent; 2010; 32(5):393-9. PubMed ID: 21070705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Success of mineral trioxide aggregate in pulpotomized primary molars.
    Farsi N; Alamoudi N; Balto K; Mushayt A
    J Clin Pediatr Dent; 2005; 29(4):307-11. PubMed ID: 16161395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An 18 month evaluation of MM-MTA pulpotomy on primary decayed molars].
    Abou Chedid JC; Mchayleh N; Khalil I; Melki B; Hardan LS
    Odontostomatol Trop; 2015 Dec; 38(152):17-24. PubMed ID: 26939217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Success rates of mineral trioxide aggregate, ferric sulfate, and sodium hypochlorite pulpotomies: A prospective 24-month study.
    Lin YT; Lin YJ
    J Formos Med Assoc; 2020 Jun; 119(6):1080-1085. PubMed ID: 31635844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.